Latest Insider Transactions at Standard Biotools Inc. (LAB)
This section provides a real-time view of insider transactions for Standard Biotools Inc. (LAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STANDARD BIOTOOLS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STANDARD BIOTOOLS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
352,072
+0.77%
|
$704,144
$2.56 P/Share
|
|
May 16
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+1.1%
|
$1,000,000
$2.54 P/Share
|
|
May 15
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+1.11%
|
$1,000,000
$2.57 P/Share
|
|
May 15
2024
|
Jeffrey G. Black SVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,779
-13.55%
|
$37,558
$2.54 P/Share
|
|
May 15
2024
|
Jeffrey G. Black SVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,631
+27.52%
|
-
|
|
Apr 08
2024
|
Michael Egholm President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
102,564
-16.17%
|
$205,128
$2.71 P/Share
|
|
Apr 05
2024
|
Hanjoon Alex Kim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,702
+25.09%
|
-
|
|
Apr 05
2024
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
212,126
+25.07%
|
-
|
|
Apr 04
2024
|
Hanjoon Alex Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,183
+33.33%
|
-
|
|
Apr 04
2024
|
Michael Egholm President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
196,512
+31.77%
|
-
|
|
Mar 18
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
46,465,458
+46.24%
|
$92,930,916
$2.75 P/Share
|
|
Mar 05
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Direct |
1,403
+0.01%
|
$2,806
$2.62 P/Share
|
|
Mar 04
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Direct |
250,000
+2.13%
|
$500,000
$2.57 P/Share
|
|
Feb 20
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
22,800
+18.04%
|
$45,600
$2.5 P/Share
|
|
Jan 05
2024
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,006
+3.84%
|
-
|
|
Jan 05
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,744,219
+50.0%
|
-
|
|
Jan 05
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,246,525
+50.0%
|
-
|
|
Jan 05
2024
|
Kathy L Hibbs |
BUY
Grant, award, or other acquisition
|
Direct |
79,412
+50.0%
|
-
|
|
Jan 05
2024
|
Thomas D. Carey |
BUY
Grant, award, or other acquisition
|
Direct |
79,412
+50.0%
|
-
|
|
Jan 05
2024
|
Troy Cox |
BUY
Grant, award, or other acquisition
|
Direct |
198,104
+32.02%
|
-
|
|
Jan 05
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Indirect |
21,538,744
+50.0%
|
-
|
|
Jan 05
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+4.61%
|
-
|
|
Oct 20
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
1,574
+1.49%
|
$3,148
$2.54 P/Share
|
|
Jul 03
2023
|
Caligan Partners LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
670,466
-7.92%
|
-
|
|
Jun 29
2023
|
Caligan Partners LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
108,879
-1.27%
|
-
|
|
Jun 14
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
26,376
+20.46%
|
-
|
|
Jun 14
2023
|
Carlos V Paya Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,376
+17.21%
|
-
|
|
Jun 14
2023
|
Frank Witney |
BUY
Grant, award, or other acquisition
|
Direct |
26,376
+26.5%
|
-
|
|
Jun 14
2023
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
26,376
+26.5%
|
-
|
|
Jun 14
2023
|
Laura Clague Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,376
+20.11%
|
-
|
|
Jun 14
2023
|
Fenel M Eloi |
BUY
Grant, award, or other acquisition
|
Direct |
26,376
+21.13%
|
-
|
|
May 19
2023
|
Jeffrey G. Black SVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
42,492
+33.07%
|
$84,984
$2.29 P/Share
|
|
May 19
2023
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
800,000
+40.0%
|
$1,600,000
$2.29 P/Share
|
|
May 19
2023
|
Eli Casdin |
BUY
Open market or private purchase
|
Indirect |
800,000
+40.0%
|
$1,600,000
$2.29 P/Share
|
|
May 18
2023
|
Jeffrey G. Black SVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
43,492
+50.0%
|
$86,984
$2.22 P/Share
|
|
May 18
2023
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
150,000
+27.27%
|
$300,000
$2.16 P/Share
|
|
May 18
2023
|
Eli Casdin |
BUY
Open market or private purchase
|
Indirect |
150,000
+27.27%
|
$300,000
$2.16 P/Share
|
|
May 17
2023
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+50.0%
|
$250,000
$1.89 P/Share
|
|
May 17
2023
|
Eli Casdin |
BUY
Open market or private purchase
|
Indirect |
250,000
+50.0%
|
$250,000
$1.89 P/Share
|
|
Apr 04
2023
|
Hanjoon Alex Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,183
+50.0%
|
-
|
|
Apr 04
2023
|
Michael Egholm President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
196,512
+48.76%
|
-
|
|
Mar 15
2023
|
Fenel M Eloi |
BUY
Grant, award, or other acquisition
|
Direct |
72,087
+50.0%
|
-
|
|
Feb 21
2023
|
Jeremy Steven Davis SVP Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,176
-29.65%
|
$12,352
$2.03 P/Share
|
|
Feb 21
2023
|
Jeremy Steven Davis SVP Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+50.0%
|
-
|
|
Feb 21
2023
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,707
-11.65%
|
$57,414
$2.03 P/Share
|
|
Feb 21
2023
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74,425
+5.61%
|
-
|
|
Feb 20
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
29,665
+28.03%
|
-
|
|
Dec 29
2022
|
Caligan Partners LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,868,037
-25.06%
|
-
|
|
Nov 21
2022
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,681
-1.54%
|
$2,681
$1.43 P/Share
|
|
Nov 21
2022
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,759
+1.48%
|
-
|